Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Aurobindo Pharma shares in focus after Eugia Steriles unit gets USFDA observations
The US FDA conducted a Pre-Approval Inspection (PAI) at Eugia Steriles, a wholly-owned subsidiary of Eugia Pharma Specialities Ltd. and a step-down subsidiary of Aurobindo Pharma, located in Parawada Mandal, Anakapalli district of Andhra Pradesh.
Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGC
Indian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despite this, the broader recovery trend remains intact above 23,700. Several companies like Sun Pharma, Tata Motors, and ONGC are in focus due to significant business developments, including acquisitions, order wins, and strategic repositioning.
Stocks to Watch today: RIL, Infosys, Wipro, HCL Tech, HDFC Bank, Acme Solar
Stocks to Watch today, June 19, 2026: Bharat Forge, Tata Motors, Jubilant Pharmova, Amber Enterprises and Mahindra Lifespace Developers are among the top stocks to remain in focus today
Sensex Today | Stock Market LIVE Updates: Nifty, Sensex set for muted open; Anthem Biosciences in focus
Sensex Today | Stock Market LIVE Updates:Today is the weekly expiry of all BSE contracts. The recent phase for the market has been a good one, with the Nifty having recovered 1,000 points from last week's low of 23,070. A close above 24,000 is also a positive.
Stocks to Watch today: RVNL, HFCL, Gujrat Gas, Hudco, Lupin, Hexware Tech
Stock to Watch today, June 18: ZF Commercial Vehicle Control Systems India, Lemon Tree Hotels, Anik Industries, and Balkrishna Industries are among the top stocks to remain in focus
Stocks in news: IFCI, Tata Motors, General Insurance Corp, Corona Remedies, HFCL
Markets extended their winning streak for the fourth consecutive session, driven by favorable global cues and sustained sector-wide buying. The Nifty reclaimed the 24,000 mark, approaching the 100-day EMA near 24,150. Stocks like IFCI, Tata Motors, and HFCL are in focus due to significant news developments, including IPO filings, turnaround projections, and major order wins.
Bollywood's box office blues return after one big hit
Hindi cinema is experiencing a box-office slump after a recent success. Several films with known casts have failed to attract audiences. Industry experts point to old storytelling, declining star appeal, and a disconnect with viewer tastes. Producers struggle to build pre-release buzz. The focus is now on delivering the right content at the right time to revive the industry.
Stock Alert: Wipro, Krishna Institute of Medical Sciences, Prime Focus, Nykaa
Shares of Kaynes Technology India are banned from F&O trading on 17 June 2026.
Blue Star: Nirmal Bang Maintains Buy on Strong Fundamentals, Long-Term Growth Drivers— Check Target Price
Blue Star's shares are likely to be in focus after Nirmal Bang reiterated its Buy' rating on the stock, citing strong fundamentals and long-term growth visibility.
Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for Biocon
Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalizing on growing demand as major pharmaceutical companies shift focus to newer weight-loss drugs. Currently the third-largest global insulin provider, Biocon is significantly expanding production. This strategic move addresses a critical gap in the market, particularly in emerging economies.
Cardinal Health options trading jumps with focus on puts By Investing.com - Investing.com India
Cardinal Health options trading jumps with focus on puts By Investing.comInvesting.com India
Hyderabad-based Pulsus to invest Rs 500 crore in Telangana AI healthcare hub, targets 6,000 jobs
Pulsus Group will invest Rs 500 crore to expand its AI healthcare and digital innovation hub in Telangana, creating 6,000 direct and 30,000 indirect jobs. This expansion, following a Supreme Court ruling upholding its SEZ status, will focus on AI-led healthcare solutions, digital services, and clinical research support.